Distinct patterns of occurrence, common associations, and survival of patients with second primary maligancies: A 5-year single institute experience with review of literature

Multiple primary malignancy (MPM) is defined as occurrence of two or more synchronous or metachronous primary malignancies. With the rise in cancer burden and meticulous screening of index primary malignancy (IPM) during treatment, increased incidence of second primary malignancy (SPM) is expected....

Full description

Saved in:
Bibliographic Details
Published in:Indian journal of pathology & microbiology Vol. 64; no. 4; pp. 725 - 731
Main Authors: Vadgaonkar, Rohit Avinash, Nayak, Sonali Susmita, Doni, Subhashreddy, Digumarti, Leela, Mullapally, Sujith Kumar, Digumarti, Raghunadharao
Format: Journal Article
Language:English
Published: India 01-10-2021
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Multiple primary malignancy (MPM) is defined as occurrence of two or more synchronous or metachronous primary malignancies. With the rise in cancer burden and meticulous screening of index primary malignancy (IPM) during treatment, increased incidence of second primary malignancy (SPM) is expected. This study was undertaken with an attempt to analyze the incidence, commonest associations, management strategies, and clinical outcomes of MPM. This is an observational retrospective study carried out in a single institute with patients registered between 1 January 2015 and 31 August 2019. The International Association of Cancer Registries and International Agency for Research on Cancer (IACR/IARC) definition was used for identification of IPM and SPM. Synchronous SPM was defined as malignancy occurring within 6 months from the diagnosis of IPM. Out of 16,461 registered patients during the study interval, 44 (0.26%) cases were found to have MPM. A total of 31 (70.5%) cases were women and 13 (29.5%) cases were men. Median age at presentation of IPM was 48 years and of SPM was 56 years, with median duration between two primaries being 38 months. Seven patients (15.9%) had synchronous malignancies. Gynecological tumors were the most common site of IPM presentation (n = 14, 31.8%) followed by breast (n = 09, 20.5%) and head and neck tumors (n = 07, 15.9%), respectively. The most common SPM was gynecological tumors (n = 12, 27.3%) followed by gastrointestinal malignancies (n = 10, 23.3%). Curative treatment was offered to 88% of patients with IPM and 70% patients with SPM. At a median follow-up of 365 days, 21 (47.72%) patients were disease free, six (13.6%) died of disease and nine (20.5%) were lost to follow-up. The study emphasizes the importance of detecting SPM as a result of improved diagnostic and screening procedures. Clinicians should be aware of it and offer multidisciplinary management.
AbstractList BACKGROUNDMultiple primary malignancy (MPM) is defined as occurrence of two or more synchronous or metachronous primary malignancies. With the rise in cancer burden and meticulous screening of index primary malignancy (IPM) during treatment, increased incidence of second primary malignancy (SPM) is expected. This study was undertaken with an attempt to analyze the incidence, commonest associations, management strategies, and clinical outcomes of MPM. MATERIALS AND METHODSThis is an observational retrospective study carried out in a single institute with patients registered between 1st January 2015 and 31st August 2019. The International Association of Cancer Registries and International Agency for Research on Cancer (IACR/IARC) definition was used for identification of IPM and SPM. Synchronous SPM was defined as malignancy occurring within 6 months from the diagnosis of IPM. RESULTSOut of 16,461 registered patients during the study interval, 44 (0.26%) cases were found to have MPM. A total of 31 (70.5%) cases were women and 13 (29.5%) cases were men. Median age at presentation of IPM was 48 years and of SPM was 56 years, with median duration between two primaries being 38 months. Seven patients (15.9%) had synchronous malignancies. Gynecological tumors were the most common site of IPM presentation (n = 14, 31.8%) followed by breast (n = 09, 20.5%) and head and neck tumors (n = 07, 15.9%), respectively. The most common SPM was gynecological tumors (n = 12, 27.3%) followed by gastrointestinal malignancies (n = 10, 23.3%). Curative treatment was offered to 88% of patients with IPM and 70% patients with SPM. At a median follow-up of 365 days, 21 (47.72%) patients were disease free, six (13.6%) died of disease and nine (20.5%) were lost to follow-up. CONCLUSIONThe study emphasizes the importance of detecting SPM as a result of improved diagnostic and screening procedures. Clinicians should be aware of it and offer multidisciplinary management.
Multiple primary malignancy (MPM) is defined as occurrence of two or more synchronous or metachronous primary malignancies. With the rise in cancer burden and meticulous screening of index primary malignancy (IPM) during treatment, increased incidence of second primary malignancy (SPM) is expected. This study was undertaken with an attempt to analyze the incidence, commonest associations, management strategies, and clinical outcomes of MPM. This is an observational retrospective study carried out in a single institute with patients registered between 1 January 2015 and 31 August 2019. The International Association of Cancer Registries and International Agency for Research on Cancer (IACR/IARC) definition was used for identification of IPM and SPM. Synchronous SPM was defined as malignancy occurring within 6 months from the diagnosis of IPM. Out of 16,461 registered patients during the study interval, 44 (0.26%) cases were found to have MPM. A total of 31 (70.5%) cases were women and 13 (29.5%) cases were men. Median age at presentation of IPM was 48 years and of SPM was 56 years, with median duration between two primaries being 38 months. Seven patients (15.9%) had synchronous malignancies. Gynecological tumors were the most common site of IPM presentation (n = 14, 31.8%) followed by breast (n = 09, 20.5%) and head and neck tumors (n = 07, 15.9%), respectively. The most common SPM was gynecological tumors (n = 12, 27.3%) followed by gastrointestinal malignancies (n = 10, 23.3%). Curative treatment was offered to 88% of patients with IPM and 70% patients with SPM. At a median follow-up of 365 days, 21 (47.72%) patients were disease free, six (13.6%) died of disease and nine (20.5%) were lost to follow-up. The study emphasizes the importance of detecting SPM as a result of improved diagnostic and screening procedures. Clinicians should be aware of it and offer multidisciplinary management.
Author Mullapally, Sujith Kumar
Digumarti, Leela
Digumarti, Raghunadharao
Nayak, Sonali Susmita
Doni, Subhashreddy
Vadgaonkar, Rohit Avinash
Author_xml – sequence: 1
  givenname: Rohit Avinash
  surname: Vadgaonkar
  fullname: Vadgaonkar, Rohit Avinash
  organization: Department of Radiation Oncology, Homi Bhabha Cancer Hospital and Research Centre, Aganampudi, Visakhapatnam, Andhra Pradesh, India
– sequence: 2
  givenname: Sonali Susmita
  surname: Nayak
  fullname: Nayak, Sonali Susmita
  organization: Department of Pathology, Homi Bhabha Cancer Hospital and Research Centre, Aganampudi, Visakhapatnam, Andhra Pradesh, India
– sequence: 3
  givenname: Subhashreddy
  surname: Doni
  fullname: Doni, Subhashreddy
  organization: Department of Radiodiagnosis, SVS Medical College, Mahabubnagar, Telangana, India
– sequence: 4
  givenname: Leela
  surname: Digumarti
  fullname: Digumarti, Leela
  organization: Department of Gynecology, KIMS ICON Hospitals, Visakhapatnam, Andhra Pradesh, India
– sequence: 5
  givenname: Sujith Kumar
  surname: Mullapally
  fullname: Mullapally, Sujith Kumar
  organization: Department of Medical Oncology, Apollo Proton Cancer Center, Chennai, India
– sequence: 6
  givenname: Raghunadharao
  surname: Digumarti
  fullname: Digumarti, Raghunadharao
  organization: Department of Medical Oncology, KIMS ICON Hospitals, Visakhapatnam, Andhra Pradesh, India
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34673592$$D View this record in MEDLINE/PubMed
BookMark eNpNkc1u1TAQha2qqP8PwAZ5yaIp_k1idlVboKgIFu068nUmxSixLx7nlr5UnxGHe0FsZmZxzpmxv2OyH2IAQl5zdqE4k-9uP3_7crGUjjOtO8H2yBEzjao0l2y_zLJpKmWEOSTHiD8Yq5XQ8oAcSlU3UhtxRF6uPWYfXKZrmzOkgDQONDo3pwTBwTl1cZpioBYxOm-zjwHPqQ09xTlt_MaOi6GYPYSM9Mnn7xTBxSJYJz_Z9EwnO_pHG5wHfE8vqa6ewSaKPjyOQH0o-_OcgcKvNSS_LN2mJNh4eFrSR18us3lOcEpeDXZEONv1E_Lw4eb-6lN19_Xj7dXlXeWENqyyvbFmYKZtuQNutYEGrFgBU0I1vVKa17WEgbtaNv2KCelKEW35Kt7qWq7kCXm7zV2n-HMGzN3k0cE42gBxxk7oVimpmZZFyrdSlyJigqHbvbtA6RZM3R9C_2Mqnje7-Hk1Qf_P8ZeL_A1bY5R7
CitedBy_id crossref_primary_10_1002_cam4_7296
Cites_doi 10.4103/0973-1482.65237
10.4103/0973-029X.86698
10.4103/0973-1482.183219
10.1097/00000658-196611000-00001
10.1097/CCO.0b013e32834bcc2a
10.1136/esmoopen-2017-000172
10.1007/s10552-013-0203-3
10.1016/S0194-59980300476-5
10.4103/2278-330X.179698
10.1007/s10549-018-4729-7
10.1186/1471-2407-14-272
10.2147/CMAR.S57378
10.1097/00000421-200302000-00015
10.1200/JCO.2011.38.2895
10.1016/j.ejca.2010.07.037
10.1634/theoncologist.12-1-20
10.4103/1319-3767.93823
10.4103/0973-1482.65241
10.1007/BF03215857
10.1158/1055-9965.EPI-11-0729
10.1001/jama.1921.02630200001001
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.4103/IJPM.IJPM_1055_20
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 0974-5130
EndPage 731
ExternalDocumentID 10_4103_IJPM_IJPM_1055_20
34673592
Genre Journal Article
Review
GeographicLocations India
GeographicLocations_xml – name: India
GroupedDBID ---
.55
29I
2WC
36B
53G
5GY
5VS
7X7
8FI
8FJ
AAWTL
ABDBF
ABJNI
ABUWG
ABXLX
ACGFO
ACGFS
ADBBV
AENEX
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BCNDV
BENPR
C1A
CCPQU
CGR
CUY
CVF
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBS
ECM
EIF
EJD
EMB
EMK
EMOBN
EOJEC
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
IAO
IEA
IHR
IL9
INH
INR
ITC
KQ8
MM.
M~E
NPM
OBODZ
OK1
OVD
PIMPY
RMW
SV3
TEORI
TR2
TUS
UKHRP
X7M
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c2590-ad9a9f09881ce1a59e7ea2be04247d4451663ef1c637db023cb022849218563b3
ISSN 0377-4929
IngestDate Fri Aug 16 20:21:45 EDT 2024
Fri Nov 22 03:00:06 EST 2024
Sat Sep 28 08:23:43 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Multidisciplinary management
multiple primary malignancies
second primary
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c2590-ad9a9f09881ce1a59e7ea2be04247d4451663ef1c637db023cb022849218563b3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
OpenAccessLink https://doi.org/10.4103/ijpm.ijpm_1055_20
PMID 34673592
PQID 2584435053
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_2584435053
crossref_primary_10_4103_IJPM_IJPM_1055_20
pubmed_primary_34673592
PublicationCentury 2000
PublicationDate 2021 Oct-Dec
2021-10-00
20211001
PublicationDateYYYYMMDD 2021-10-01
PublicationDate_xml – month: 10
  year: 2021
  text: 2021 Oct-Dec
PublicationDecade 2020
PublicationPlace India
PublicationPlace_xml – name: India
PublicationTitle Indian journal of pathology & microbiology
PublicationTitleAlternate Indian J Pathol Microbiol
PublicationYear 2021
References Vaamonde (R10-17-20240829) 2003; 129
Etiz (R11-17-20240829) 2017; 13
Coyte (R12-17-20240829) 2014; 14
Coebergh (R17-17-20240829) 2010; 46
Hayat (R19-17-20240829) 2007; 12
Kumar (R4-17-20240829) 2010; 6
Owen (R9-17-20240829) 1921; 76
Hankey (R20-17-20240829) 1999; 8
Kollias (R25-17-20240829) 2001; 25
Bishen (R5-17-20240829) 2011; 15
Kushner (R24-17-20240829) 2018; 170
Demandante (R13-17-20240829) 2003; 26
Jena (R6-17-20240829) 2016; 5
Amer (R18-17-20240829) 2014; 5
Parry (R1-17-20240829) 2011; 20
Angurana (R3-17-20240829) 2010; 6
Spratt (R14-17-20240829) 1966; 164
Weir (R16-17-20240829) 2013; 24
Vogt (R8-17-20240829) 2017; 2
Leone (R21-17-20240829) 2011; 23
Lacouture (R22-17-20240829) 2012; 30
Rajalingam (R2-17-20240829) 2012; 18
Warren (R15-17-20240829) 1932; 16
Ricks (R23-17-20240829) 2015; 14
References_xml – volume: 6
  start-page: 230
  year: 2010
  ident: R3-17-20240829
  article-title: Quadruple malignancy in a single patient: A case report and comprehensive review of literature
  publication-title: J Can Res Ther
  doi: 10.4103/0973-1482.65237
  contributor:
    fullname: Angurana
– volume: 15
  start-page: 306
  year: 2011
  ident: R5-17-20240829
  article-title: A case of dual malignancy: Presenting the necessity for extensive sampling for pathologic examination
  publication-title: J Oral Maxillofac Pathol
  doi: 10.4103/0973-029X.86698
  contributor:
    fullname: Bishen
– volume: 13
  start-page: 16
  year: 2017
  ident: R11-17-20240829
  article-title: Multiple primary malignant neoplasms: A 10-year experience at a single institution from Turkey
  publication-title: J Cancer Res Ther
  doi: 10.4103/0973-1482.183219
  contributor:
    fullname: Etiz
– volume: 164
  start-page: 775
  year: 1966
  ident: R14-17-20240829
  article-title: Incidence of multiple primary cancers per man-year of follow up: 20-year review from the Ellis Fischel State Cancer Hospital
  publication-title: Ann Surg
  doi: 10.1097/00000658-196611000-00001
  contributor:
    fullname: Spratt
– volume: 23
  start-page: 672
  year: 2011
  ident: R21-17-20240829
  article-title: Therapy-related myeloid neoplasms
  publication-title: Curr Opin Oncol
  doi: 10.1097/CCO.0b013e32834bcc2a
  contributor:
    fullname: Leone
– volume: 2
  start-page: e000172
  year: 2017
  ident: R8-17-20240829
  article-title: Multiple primary tumours: Challenges and approaches, a review
  publication-title: ESMO Open
  doi: 10.1136/esmoopen-2017-000172
  contributor:
    fullname: Vogt
– volume: 24
  start-page: 1231
  year: 2013
  ident: R16-17-20240829
  article-title: The effect of multiple primary rules on population-based cancer survival
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-013-0203-3
  contributor:
    fullname: Weir
– volume: 129
  start-page: 65
  year: 2003
  ident: R10-17-20240829
  article-title: Second primary malignancies in patients with cancer of the head and neck
  publication-title: Otolaryngol Head Neck Surg
  doi: 10.1016/S0194-59980300476-5
  contributor:
    fullname: Vaamonde
– volume: 16
  start-page: 1358
  year: 1932
  ident: R15-17-20240829
  article-title: Multiple primary malignant tumors. A survey of the literature and a statistical study
  publication-title: Am J Cancer
  contributor:
    fullname: Warren
– volume: 5
  start-page: 29
  year: 2016
  ident: R6-17-20240829
  article-title: Multiple primary cancers: An enigma
  publication-title: South Asian J Cancer
  doi: 10.4103/2278-330X.179698
  contributor:
    fullname: Jena
– volume: 170
  start-page: 45
  year: 2018
  ident: R24-17-20240829
  article-title: Long-term risk of second malignancies in women after breast conservation therapy for ductal carcinoma in situ or early-stage breast cancer
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-018-4729-7
  contributor:
    fullname: Kushner
– volume: 14
  start-page: 222
  year: 2015
  ident: R23-17-20240829
  article-title: Successes and challenges of PARP inhibitors in cancer therapy
  publication-title: Front Oncol
  contributor:
    fullname: Ricks
– volume: 14
  start-page: 272
  year: 2014
  ident: R12-17-20240829
  article-title: Second primary cancer risk - the impact of applying different definitions of multiple primaries: Results from a retrospective population-based cancer registry study
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-14-272
  contributor:
    fullname: Coyte
– volume: 5
  start-page: 119
  year: 2014
  ident: R18-17-20240829
  article-title: Multiple neoplasms, single primaries, and patient survival
  publication-title: Cancer Manag Res
  doi: 10.2147/CMAR.S57378
  contributor:
    fullname: Amer
– volume: 26
  start-page: 79
  year: 2003
  ident: R13-17-20240829
  article-title: Multiple primary malignant neoplasms
  publication-title: Am J Clin Oncol
  doi: 10.1097/00000421-200302000-00015
  contributor:
    fullname: Demandante
– volume: 30
  start-page: 329
  year: 2012
  ident: R22-17-20240829
  article-title: Induction of cutaneous squamous cell carcinomas by RAF inhibitors: Cause for concern?
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2011.38.2895
  contributor:
    fullname: Lacouture
– volume: 46
  start-page: 2660
  year: 2010
  ident: R17-17-20240829
  article-title: The long road towards cancer prevention: 4 steps backward and 8 forward
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2010.07.037
  contributor:
    fullname: Coebergh
– volume: 12
  start-page: 20
  year: 2007
  ident: R19-17-20240829
  article-title: Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program
  publication-title: Oncologist
  doi: 10.1634/theoncologist.12-1-20
  contributor:
    fullname: Hayat
– volume: 18
  start-page: 143
  year: 2012
  ident: R2-17-20240829
  article-title: Non-familial double malignancy of the colon and ampulla of vater: A case report and review of literature
  publication-title: Saudi J Gastroenterol
  doi: 10.4103/1319-3767.93823
  contributor:
    fullname: Rajalingam
– volume: 6
  start-page: 227
  year: 2010
  ident: R4-17-20240829
  article-title: Synchronous anaplastic oligodendroglioma and carcinoma tongue: A rare association
  publication-title: J Cancer Res Ther
  doi: 10.4103/0973-1482.65241
  contributor:
    fullname: Kumar
– volume: 25
  start-page: 1117
  year: 2001
  ident: R25-17-20240829
  article-title: Prognostic significance of synchronous and metachronous bilateral breast cancer
  publication-title: World J Surg
  doi: 10.1007/BF03215857
  contributor:
    fullname: Kollias
– volume: 8
  start-page: 1117
  year: 1999
  ident: R20-17-20240829
  article-title: The surveillance, epidemiology, and end results program: A national resource
  publication-title: Cancer Epidemiol Biomarkers Prev
  contributor:
    fullname: Hankey
– volume: 20
  start-page: 1996
  year: 2011
  ident: R1-17-20240829
  article-title: Cancer survivors: A booming population
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-11-0729
  contributor:
    fullname: Parry
– volume: 76
  start-page: 1329
  year: 1921
  ident: R9-17-20240829
  article-title: Multiple malignant neoplasm
  publication-title: JAMA
  doi: 10.1001/jama.1921.02630200001001
  contributor:
    fullname: Owen
SSID ssj0064253
Score 2.2918973
SecondaryResourceType review_article
Snippet Multiple primary malignancy (MPM) is defined as occurrence of two or more synchronous or metachronous primary malignancies. With the rise in cancer burden and...
BACKGROUNDMultiple primary malignancy (MPM) is defined as occurrence of two or more synchronous or metachronous primary malignancies. With the rise in cancer...
SourceID proquest
crossref
pubmed
SourceType Aggregation Database
Index Database
StartPage 725
SubjectTerms Adolescent
Adult
Aged
Child
Female
Head and Neck Neoplasms - complications
Head and Neck Neoplasms - epidemiology
Head and Neck Neoplasms - mortality
Humans
Incidence
India - epidemiology
Male
Middle Aged
Neoplasms, Multiple Primary - epidemiology
Neoplasms, Multiple Primary - mortality
Neoplasms, Second Primary - epidemiology
Neoplasms, Second Primary - etiology
Neoplasms, Second Primary - mortality
Prevalence
Retrospective Studies
Survival Rate
Tertiary Care Centers - statistics & numerical data
Young Adult
Title Distinct patterns of occurrence, common associations, and survival of patients with second primary maligancies: A 5-year single institute experience with review of literature
URI https://www.ncbi.nlm.nih.gov/pubmed/34673592
https://search.proquest.com/docview/2584435053
Volume 64
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1db9MwFLW6ISFe0PguA2QknmCBfLlpeKtopw11A2kd2ltkO04X0SbS0k7an-I3cq8_kgBCGg-8RG2k3Ko9p9fn2tfHhLwJIDHKIsm9MahzLxZh4IkRTz0VhDJWUBWl2vHm6Cw5vRhPZ_FsMHBm_t29_4o03AOscefsP6DdBoUb8BowhyugDtdb4T7FP22FhsTaOdN0udVSah8mM2MOH7vGJuQOmcY1cTZbSB3XRqBay1W7_63Byhk9BYw7xRr0-1Kf7NuYze3Mu0FPIJx6WKERietBUK2XsonT7ZVZtY7OfYV8XGmzhJ6jBR6abJyikKbrsrOOcmz5xvMlr6vvrln8sty8m1yXFW-6yW5-w3XiP9OlB3YjrctNOyZNa320FebRS3jqSuV5G31aLrEP3fQ9zJVa8f5USRi0TXcw0tlJzyT2WGBXgmz-Ny7qludxL5knZku21QWJGa1-H3LiwEfri-PPX0_e4yXDE0ez0O_GV9dTcPolOzyfz7PF7GKxQ-6EkBnbOQAjHaAWZJFZesewH_4I-qt4-ktFpJXRYo_ctyUNnRguPiADVT0kd09s08Yj8sNRkjpK0rqgHSUPqCEk7RPygAIdqaMjPuDoSJFG1NCRWjrSHh0_0gk1ZKSGjLQlI-3IaKIYMmL0joyPyfnhbPHpyLPHhHgSanff43nK08JPx-NAqoCzVCWKh0Lhon6SowEfqGpVBHIUJbkAjSoFmj7FKahbNopE9ITsVnWlnhHKRnIUFKEULOYxT5nwRSFEyiSDt0lRDMlb9_tn9gsCNBmClWmc-mANyWuHUAY5GxfieKXqbZOFoPqhTIHxb0ieGujacBEol4il4fNbPL1P7nU0f0F2N1db9ZLsNPn2lebVT_FmyzA
link.rule.ids 315,782,786,866,27933,27934
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Distinct+patterns+of+occurrence%2C+common+associations%2C+and+survival+of+patients+with+second+primary+maligancies%3A+A+5-year+single+institute+experience+with+review+of+literature&rft.jtitle=Indian+journal+of+pathology+%26+microbiology&rft.au=Vadgaonkar%2C+Rohit+Avinash&rft.au=Nayak%2C+Sonali+Susmita&rft.au=Doni%2C+Subhashreddy&rft.au=Digumarti%2C+Leela&rft.date=2021-10-01&rft.eissn=0974-5130&rft.volume=64&rft.issue=4&rft.spage=725&rft.epage=731&rft_id=info:doi/10.4103%2FIJPM.IJPM_1055_20&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0377-4929&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0377-4929&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0377-4929&client=summon